Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

VR-Cognitive Behavioral Therapy Prehabilitation for Spinal Deformity Surgery (VR-CBT)

20 août 2026 mis à jour par: Michael Oh, University of California, Irvine

A Randomized Controlled Pilot Trial Evaluating Virtual Reality-Based Cognitive Behavioral Therapy (VR-CBT) as a Prehabilitation Intervention for Adult Spinal Deformity Surgery

The goal of this clinical trial is to learn whether a virtual reality-based cognitive behavioral therapy (VR-CBT) prehabilitation program can improve recovery and quality of life for adults undergoing elective spine surgery. The main questions it aims to answer are:

Does participating in an 8-week VR-CBT prehabilitation program before surgery improve physical function and pain-related outcomes at 12 months after surgery?

Does VR-CBT prehabilitation reduce postoperative anxiety, depression, and pain interference compared with usual preoperative care?

Researchers will compare participants who receive the VR-CBT prehabilitation program plus usual care to participants who receive usual preoperative care alone to see if the VR-CBT program leads to better recovery and patient-reported outcomes.

Participants will:

Use a VR headset at home to complete structured CBT-based prehabilitation sessions over 8 weeks before surgery.

Attend routine clinic visits and complete questionnaires about pain, function, mood, and quality of life before surgery and through 12 months after surgery.

Allow the research team to review their medical records for information about surgery, complications, and postoperative recovery.

Aperçu de l'étude

Description détaillée

Elective spine surgery is commonly performed to address pain, neurologic symptoms, and functional limitations, yet many patients experience persistent postoperative pain, anxiety, and impaired quality of life despite technically successful procedures. Psychological factors such as catastrophizing, fear of movement, and low self-efficacy are strongly associated with poorer recovery trajectories after spine surgery. Virtual reality-based cognitive behavioral therapy (VR-CBT) is an emerging, scalable approach that can deliver structured coping skills training and exposure-based exercises in an immersive environment, potentially enhancing preoperative preparedness and postoperative recovery.

This multi-site, interventional clinical trial will evaluate two formats of a CBT-based prehabilitation program for adults undergoing elective spine surgery at UC Irvine and Hoag Memorial Hospital Presbyterian. Each participant's study involvement lasts approximately 12 months and includes an 8-week preoperative prehabilitation period followed by postoperative follow-up through 12 months after surgery. The primary objective is to determine whether delivering spine-focused CBT prehabilitation using a virtual reality platform (VR-CBT) leads to better patient-reported outcomes and functional recovery at 12 months after surgery compared with the same CBT prehabilitation delivered without virtual reality. Secondary objectives include examining the effects of VR-CBT versus non-VR CBT on pain intensity, pain interference, mood symptoms (e.g., anxiety and depression), health-related quality of life, and patient satisfaction with care.

Eligible patients scheduled for qualifying spine procedures at participating sites will be approached in the clinic and, after providing informed consent, enrolled and assigned either to receive CBT prehabilitation delivered with VR-based exposure (VR-CBT) or to receive the same CBT prehabilitation without VR (standard CBT), in both cases alongside usual perioperative clinical care. The VR-CBT program consists of multiple home-based sessions delivered via a virtual reality headset and software platform over the 8-week preoperative window. Session content focuses on psychoeducation about surgery and recovery, cognitive restructuring, relaxation and mindfulness skills, graded exposure to movement and pain-related cues, and rehearsal of adaptive coping strategies in immersive VR environments. In the comparator arm, participants receive the same CBT content through non-VR delivery methods (e.g., in-person or video-based sessions and written/online materials) without access to VR technology.

Research-specific assessment visits of approximately 45-60 minutes are aligned whenever possible with routine clinical visits at each site to minimize participant burden. Participants complete validated questionnaires assessing pain, function, and psychosocial factors at baseline (before starting CBT with or without VR), after the prehabilitation period, and at multiple postoperative time points through 12 months. Additional data are abstracted from the electronic medical record, including details of the surgical procedure, perioperative complications, healthcare utilization, and opioid prescriptions. These data will be used to explore whether VR-CBT prehabilitation influences not only patient-reported outcomes but also clinical recovery metrics and resource use across sites.

Safety monitoring is conducted under the oversight of the Institutional Review Boards at each participating institution, including UC Irvine (ZotIRB). Adverse events, including unexpected psychological distress or intolerance of VR use, are recorded throughout study participation and managed according to institutional policies. Because this is a behavioral intervention study that does not involve an FDA-regulated drug or device, no Investigational New Drug (IND) application or Investigational Device Exemption (IDE) is required, and an independent data monitoring committee is not convened. Results from this trial are intended to inform whether VR-CBT prehabilitation is a feasible and potentially effective strategy to improve recovery and long-term outcomes for patients undergoing spine surgery, and to guide the design of future larger-scale studies.

Type d'étude

Interventionnel

Inscription (Estimé)

80

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

  • Nom: Micheal Y Oh, MD
  • Numéro de téléphone: 714-456-7012
  • E-mail: ohm2@hs.uci.edu

Sauvegarde des contacts de l'étude

Lieux d'étude

    • California
      • Irvine, California, États-Unis, 92617
        • UCI Health - Orthopaedic Spine Center (Wen Center for Advanced Care)
        • Contact:
        • Contact:
      • Newport Beach, California, États-Unis, 92663
        • Hoag Memorial Hospital Presbyterian (Hoag Hospital Newport Beach)
        • Contact:
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Non

La description

Inclusion Criteria

  • Adults between 18 and 75 years old.
  • Diagnosis of thoracolumbar adult spinal deformity (ASD), including but not limited to adult scoliosis, kyphosis, or spondylolisthesis, confirmed radiographically using SRS-Schwab classification criteria.
  • Scheduled for elective spinal surgery involving fusion of more than four spinal levels.
  • Moderate to severe chronic pain, assessed using the Visual Analog Scale (VAS) or Numeric Rating Scale (NRS).
  • Ability to participate in an 8-week preoperative prehabilitation program.
  • Adequate cognitive functioning and English language skills to engage in CBT or VR-CBT treatments.
  • Ability to provide written informed consent and adhere to study procedures and follow-up visits.

Exclusion Criteria

  • Neurological conditions that significantly impact cognition or mobility.
  • Active spinal infection, malignancy, or significant spinal trauma.
  • Unmanaged medical conditions that could affect participation in the study.
  • Pregnancy or plans to become pregnant during the study period.
  • Severe visual impairment, claustrophobia, or other conditions that prevent safe use of VR technology.
  • Cognitive impairment preventing adherence to study procedures.
  • History of non-compliance with medical treatment or failure to adhere to study visits and follow-up.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: CBT Prehabilitation with Virtual Reality Exposure
Participants receive a spine-focused CBT prehabilitation program delivered using a virtual reality platform (VR-CBT) in addition to usual perioperative clinical care. The 8-week preoperative program includes home-based VR sessions targeting psychoeducation about surgery and recovery, cognitive restructuring, relaxation and mindfulness, and graded exposure to movement and pain-related cues in immersive VR environments
A spine-focused cognitive behavioral therapy (CBT) prehabilitation program delivered using a virtual reality platform. Over 8 weeks before surgery, participants complete home-based VR sessions via a headset and software that provide psychoeducation about surgery and recovery, cognitive restructuring exercises, relaxation and mindfulness training, and graded exposure to movement and pain-related cues in immersive virtual environments. This intervention is administered in addition to usual perioperative clinical care.
Comparateur actif: CBT Prehabilitation without Virtual Reality
Participants receive the same spine-focused CBT prehabilitation content delivered without VR (standard CBT sessions/materials) in addition to usual perioperative clinical care. The 8-week preoperative program uses non-VR delivery methods (e.g., in-person or video-based sessions and written/online materials) covering psychoeducation, cognitive restructuring, relaxation and mindfulness, and graded exposure to movement and pain-related cues without VR technology.
A spine-focused CBT prehabilitation program delivered without VR. Over 8 weeks before surgery, participants receive the same CBT content using non-VR methods covering psychoeducation about surgery and recovery, cognitive restructuring, relaxation and mindfulness, and graded exposure to movement and pain-related cues. This intervention is administered in addition to usual perioperative clinical care.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Change in Oswestry Disability Index (ODI) Score from Baseline to 12 Months After Surgery
Délai: Baseline (preoperative) and 12 months after surgery
The Oswestry Disability Index (ODI) is a patient-reported measure of back pain-related disability with scores ranging from 0 to 100, where higher scores indicate greater disability. Change is calculated as ODI score at 12 months after surgery minus the baseline (preoperative) ODI score.
Baseline (preoperative) and 12 months after surgery
Change in pain intensity (VAS/NRS) from baseline to 12 months after surgery
Délai: Baseline (preoperative) and 12 months after surgery
Pain intensity will be assessed using a 0-10 Visual Analog Scale (VAS) or Numeric Rating Scale (NRS), where higher scores indicate greater pain. Change in pain intensity will be calculated as the score at 12 months after surgery minus the baseline (preoperative) score
Baseline (preoperative) and 12 months after surgery
Change in functional mobility (Timed Up and Go and Functional Gait Assessment) from baseline to 12 months after surgery
Délai: Baseline (preoperative) and 12 months after surgery.
Functional mobility will be measured using the Timed Up and Go (TUG) test and the Functional Gait Assessment (FGA). TUG records the time in seconds required for a patient to stand from a chair, walk 3 meters, turn, walk back, and sit; longer times indicate worse mobility. FGA is a multi-item clinician-rated scale of dynamic gait stability with scores typically ranging from 0 to 30, where higher scores indicate better gait function. Change in functional mobility will be calculated as TUG time and FGA score at 12 months after surgery compared with baseline (preoperative) values.
Baseline (preoperative) and 12 months after surgery.

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Change in psychological distress (Pain Catastrophizing Scale) from baseline to 12 months after surgery
Délai: Baseline (preoperative) and 12 months after surgery.
Psychological distress related to pain will be measured using the Pain Catastrophizing Scale (PCS), which assesses rumination, magnification, and helplessness about pain. PCS total scores (higher scores indicating greater catastrophizing) at 12 months after surgery will be compared with baseline scores to quantify change.
Baseline (preoperative) and 12 months after surgery.
Change in fear-avoidance beliefs (Fear-Avoidance Beliefs Questionnaire) from baseline to 12 months after surgery
Délai: Baseline (preoperative) and 12 months after surgery
Fear-avoidant behaviors will be assessed using the Fear-Avoidance Beliefs Questionnaire (FABQ), which evaluates fear-based beliefs about physical activity and work in relation to pain. FABQ subscale and total scores (higher scores indicating greater fear-avoidance) at 12 months after surgery will be compared with baseline scores.
Baseline (preoperative) and 12 months after surgery
Change in postural awareness score from baseline to 12 months after surgery
Délai: Baseline (preoperative) and 12 months after surgery.
Postural awareness will be assessed using a study-specific postural awareness measure (e.g., questionnaire or rating scale) designed to capture patients' awareness of spinal alignment and posture during daily activities. Higher scores will reflect greater postural awareness. Change in postural awareness will be calculated as the score at 12 months after surgery compared with baseline.
Baseline (preoperative) and 12 months after surgery.
Postoperative opioid use through 12 months after surgery
Délai: From hospital discharge through 12 months after surgery.
Opioid use will be quantified using prescription and medication-use data abstracted from the electronic medical record. Outcomes will include total opioid consumption expressed in morphine milligram equivalents (MME) and patterns of opioid prescribing over the postoperative period.
From hospital discharge through 12 months after surgery.
Postoperative functional recovery through 12 months after surgery
Délai: Baseline (preoperative) and repeated postoperative assessments through 12 months after surgery.
Postoperative functional recovery will be evaluated using a composite of functional mobility assessments (Timed Up and Go, Functional Gait Assessment) and patient-reported functional measures specified in the full protocol. Recovery will be characterized by the magnitude and trajectory of improvement in these measures over the 12-month postoperative period.
Baseline (preoperative) and repeated postoperative assessments through 12 months after surgery.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 septembre 2026

Achèvement primaire (Estimé)

28 novembre 2028

Achèvement de l'étude (Estimé)

28 novembre 2028

Dates d'inscription aux études

Première soumission

17 août 2026

Première soumission répondant aux critères de contrôle qualité

17 août 2026

Première publication (Réel)

20 août 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

24 août 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

20 août 2026

Dernière vérification

1 août 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • STUDY00001948 (Tufts Medical Center)

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner